{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:05:10Z","timestamp":1781575510589,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.drugalcdep.2012.08.025","type":"journal-article","created":{"date-parts":[[2012,9,16]],"date-time":"2012-09-16T17:45:20Z","timestamp":1347817520000},"page":"206-213","source":"Crossref","is-referenced-by-count":23,"title":["Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans"],"prefix":"10.1016","volume":"128","author":[{"given":"Lawrence P.","family":"Carter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad J.","family":"Reissig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Klinedinst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland R.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam Z.","family":"Mintzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0005","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1196\/annals.1432.003","article-title":"Dextromethorphan","volume":"1139","author":"Banken","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0010","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2165\/00002018-199207030-00004","article-title":"Dextromethorphan. An overview of safety issues","volume":"7","author":"Bem","year":"1992","journal-title":"Drug Saf."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0015","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/01.pec.0000148039.14588.d0","article-title":"Dextromethorphan abuse","volume":"20","author":"Boyer","year":"2004","journal-title":"Pediatr. Emerg. Care"},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00213-009-1589-1","article-title":"Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers","volume":"206","author":"Carter","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0025","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1124\/jpet.107.119693","article-title":"Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects","volume":"322","author":"Carter","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0030","doi-asserted-by":"crossref","unstructured":"Carter, L.P., Kleykamp, B.A., Griffiths, R.R., Mintzer, M.Z., 2012. Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers. Psychopharmacology (Berl.), in press.","DOI":"10.1007\/s00213-012-2883-x"},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0035","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/sj.npp.1301146","article-title":"Relative abuse liability of GHB in humans: a comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB","volume":"31","author":"Carter","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0006-8993(94)90771-4","article-title":"Interactions of dextromethorphan with the N-methyl-d-aspartate receptor-channel complex: single channel recordings","volume":"666","author":"Church","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0045","unstructured":"Erowid Dextromethorphan Legal Status Page. http:\/\/www.erowid.org\/chemicals\/dxm\/dxm_law.shtml (accessed 24.06.12)."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0050","unstructured":"FDA Briefing Information, Dextromethorphan (DXM), for the September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee. http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/DrugSafetyandRiskManagementAdvisoryCommittee\/UCM224446.pdf (accessed 26.02.12)."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0055","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0026-895X(25)08814-5","article-title":"High affinity [3H]dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel","volume":"41","author":"Franklin","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0060","first-page":"732","article-title":"Measures of association for cross-classifications","volume":"49","author":"Goodman","year":"1954","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0065","unstructured":"H.R. 1259 (111th): Dextromethorphan Distribution Act of 2009. http:\/\/www.govtrack.us\/congress\/bills\/111\/hr1259 (accessed 24.06.12)."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0018407","article-title":"Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers","volume":"18","author":"Kleykamp","year":"2010","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0075","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1037\/1064-1297.14.4.439","article-title":"Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults","volume":"14","author":"Lofwall","year":"2006","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0080","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3758\/BF03203313","article-title":"An automated version of the digit symbol substitution test (DSST)","volume":"14","author":"McLeod","year":"1982","journal-title":"Behav. Res. Methods Instrument"},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0085","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00008877-200212000-00007","article-title":"Alcohol and triazolam: differential effects on memory, psychomotor performance and subjective ratings of effects","volume":"13","author":"Mintzer","year":"2002","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0090","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/01.fbp.0000172736.11994.3c","article-title":"An abuse liability comparison of flunitrazepam and triazolam in sedative drug abusers","volume":"16","author":"Mintzer","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0095","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3758\/CABN.7.2.120","article-title":"Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes","volume":"7","author":"Mintzer","year":"2007","journal-title":"Cogn. Affect. Behav. Neurosci."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.coph.2004.08.008","article-title":"PCP: from pharmacology to modelling schizophrenia","volume":"5","author":"Morris","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0105","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00702-007-0668-x","article-title":"Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment","volume":"114","author":"Newell","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0110","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0028-3908(95)00092-K","article-title":"Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo","volume":"34","author":"Parsons","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-012-2680-6","article-title":"High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens","volume":"3","author":"Reissig","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0120","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1331\/JAPhA.2009.08091","article-title":"Dextromethorphan abuse: clinical effects and management","volume":"49","author":"Romanelli","year":"2009","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archpsyc.57.3.291","article-title":"Dextromethorphan challenge in alcohol-dependent patients and controls","volume":"57","author":"Schutz","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-3-540-74806-9_15","article-title":"Ketamine","author":"Sinner","year":"2008","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0135","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s007020070071","article-title":"NMDA receptor challenge with dextromethorphan - subjective response, neuroendocrinological findings and possible clinical implications","volume":"107","author":"Soyka","year":"2000","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1037\/0096-3445.117.1.34","article-title":"Pragmatics of measuring recognition memory: applications to dementia and amnesia","volume":"117","author":"Snodgrass","year":"1988","journal-title":"J. Exp. Psychol. Gen."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0145","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3171\/jns.1996.84.5.0860","article-title":"Dose escalation safety and tolerance study of the N-methyl-D-aspartate antagonist dextromethorphan in neurosurgery patients","volume":"84","author":"Steinberg","year":"1996","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0150","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0001-6918(69)90055-9","article-title":"The discovery of processing stages: extensions of Donder's method","volume":"30","author":"Sternberg","year":"1969","journal-title":"Acta Psychol. (Amst.)"},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.expneurol.2007.06.013","article-title":"A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder","volume":"207","author":"Werling","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0160","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/15563650.2011.585429","article-title":"Monitoring trends in dextromethorphan abuse using the National Poison Data System: 2000\u20132010","volume":"49","author":"Wilson","year":"2011","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0180","series-title":"Proceedings of the Twentieth Annual SAS Users Group Conference","article-title":"Comparing the SAS GLM and MIXED procedures for repeated measures","author":"Wolfinger","year":"1995"},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0165","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00004714-199808000-00014","article-title":"Psychotropic effects of dextromethorphan are altered by the CYP2D6 polymorphism: a pilot study","volume":"18","author":"Zawertailo","year":"1998","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2012.08.025_bib0170","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.addbeh.2005.02.005","article-title":"Side effects of dextromethorphan abuse, a case series","volume":"30","author":"Ziaee","year":"2005","journal-title":"Addict. Behav."}],"updated-by":[{"DOI":"10.1016\/j.drugalcdep.2013.06.006","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000}}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612003420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612003420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:35:30Z","timestamp":1744151730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871612003420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0376871612003420"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.08.025","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}